Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206175 · ClinicalTrials.gov registry record · NA
Demonstration of a Digital Care Program for Methamphetamine Use Disorder
A NA study of Methamphetamine Abuse, sponsored by Affect Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05206175 is a NA study of Methamphetamine Abuse that has completed, run by Affect Therapeutics. The registered enrollment target is 100 participants, below the 202-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05206175, a NA study of Methamphetamine Abuse, has completed, sponsored by Affect Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This Phase I Small Business Innovation Research (SBIR) project will examine the technical merit and real-world feasibility of the Affect smartphone application ("app") as the core component of the Affect digital care program for treatment of methamphetamine use disorder (MUD).
Conditions Studied
Interventions
- OTHER Affect Treatment Program for Methamphetamine Use Disorder
Study Locations (1)
New York
- Affect Therapeutics - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05206175
The ClinicalTrials.gov registry entry for NCT05206175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 202-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (50% lower). The listed sponsor is Affect Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 1 intervention - of which Affect Treatment Program for Methamphetamine Use Disorder is the first listed.
NCT05206175 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05206175 about?
NCT05206175 is a clinical study titled "Demonstration of a Digital Care Program for Methamphetamine Use Disorder". This Phase I Small Business Innovation Research (SBIR) project will examine the technical merit and real-world feasibility of the Affect smartphone application ("app") as the core component of the Affect digital care program for treatment of methamphetamine use disorder (MUD).
What is the current status of trial NCT05206175?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2022-02-14. Estimated completion is 2022-12-31.
What conditions does trial NCT05206175 study?
This clinical trial studies the following conditions: Methamphetamine Abuse.
What interventions are being tested in trial NCT05206175?
The interventions under investigation include: Affect Treatment Program for Methamphetamine Use Disorder (OTHER).
Who is sponsoring clinical trial NCT05206175?
This trial is sponsored by Affect Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05206175 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
-
Mood and Decision-making in Methamphetamine Use Disorder
RECRUITING · NA
-
Contingency Management for Drug Use: Does Age Matter?
ACTIVE NOT RECRUITING · NA
-
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.